Research & Development
Hematology: Page 2
Beckman, Scopio to partner on blood smear platforms
Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.
July 19, 2022
Philips adopting proteomics results for patient management
The integration of proteomics results from the blood-based test -- along with the radiologic and patient history data currently used to determine treatment decisions -- can help create diagnostic efficiency for cancer care centers, Philips said.
June 29, 2022
Quotient discloses underwritten public offering price
The company said the aggregate net proceeds to Quotient from this offering are expected to be approximately $18.5 million. The company also offered all of the securities sold. Furthermore, Quotient granted the underwriters a 30-day option to purchase up to an additional 10,000,000 of its ordinary shares. The company said that it plans to use net proceeds to fund the ongoing development and commercialization of its MosaiQ microarray menu. It added that funds will go toward working capital, operating expenses, and other general corporate purposes.
June 23, 2022
Blood grouping, typing market estimated at $945 million
The overall market is expected to stabilize in 2022 and grow at a 1% compound annual growth rate (CAGR) through 2026 when revenues could reach $1 billion, according to the report, which is published by Kalorama Information, a sister publication of LabPulse.com.
June 16, 2022
PerkinElmer, Novartis expand newborn screening for SCD
In collaboration with the Novartis Africa Sickle Cell Disease program, PerkinElmer aims to expand advocacy efforts to educate patients, caregivers, and communities about the importance of newborn screening and early intervention with hydroxyurea and other SCD treatments.
June 15, 2022
FDA clears Scopio Labs hematology analysis platform
Tel Aviv, Israel-based Scopio said the X100HT is a full-field digital imaging and artificial intelligence (AI)-enabled platform that combines high throughput with high resolution for hematological analysis.
June 9, 2022
Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
Roche reports flat diagnostics revenue growth for 2022
Duke University developing blood test to detect osteoarthritis progression in the knee
SeekIn receives CE Mark for karyotyping kit
Designed to show copy number alteration patterns in leukemia patients based on shallow whole-genome sequencing, the test can help hematologists make diagnoses and prognostic decisions based on European Leukemia Net, Revised International Prognostic Scoring System, or Revised International Staging System guidelines, according to the vendor.
April 6, 2022
PixCell signs MakGroup as distributor for the UAE
Dubai-based MakGroup will have exclusive distribution rights in the UAE for HemoScreen, a five-part, differential complete blood count analyzer that can provide results in five minutes, according to PixCell.
April 6, 2022
Revenues from coagulation lab and POC tests near $4B in 2021
Hemostasis (coagulation) is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis (the breakup of blood clots), and platelet aggregation are a part of this process.
February 15, 2022
Personalis collaborates with UC San Diego Health
Under the collaboration, UC San Diego healthcare professionals will utilize a comprehensive genomic profiling test from Personalis to help guide therapy decisions and clinical trial treatment options, according to the vendor.
February 14, 2022
Scopio completes $50M funding round
The company's workflow digitizes and analyzes blood samples. Its X100 digital slide-scanning device uses computational photography to image entire sample slides and zoom in on individual cells. Its full-field peripheral blood smear application also supports detection, preclassification, and quantification for blood cells. The company is also working on artificial intelligence (AI) applications.
February 10, 2022
ASH-ASPHO offers guidance on pediatric hematology tests
The two testing recommendations regarding hematologic testing in pediatric patients are as follows:
January 30, 2022
Page 2 of 6